Liu Chi-Hung, Huang Bing-Shen, Lin Chien-Yu, Yeh Chih-Hua, Lee Tsong-Hai, Wu Hsiu-Chuan, Chang Chien-Hung, Chang Ting-Yu, Huang Kuo-Lun, Jiang Jian-Lin, Chang Joseph Tung-Chieh, Chang Yeu-Jhy
Stroke Center, Department of Neurology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan 33333, Taiwan.
Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 33333, Taiwan.
J Pers Med. 2022 Jun 29;12(7):1060. doi: 10.3390/jpm12071060.
Background and purpose: to investigate the frequency of cervical−cranial vascular complications soon after radiation therapy (RT) and identify differences among patients with various types of head and neck cancer (HNC). Methods: We enrolled 496 patients with HNC who had received their final RT dose in our hospital. These patients underwent carotid duplex ultrasound (CDU) for monitoring significant carotid artery stenosis (CAS). Brain imaging were reviewed to detect vertebral, intracranial artery stenosis, or preexisted CAS before RT. Primary outcome was significant CAS at the internal or common carotid artery within first 5 years after RT. We categorized the patients into nasopharyngeal carcinoma (NPC) and non-NPC groups and compared the cumulative occurrence of significant CAS between the groups using Kaplan−Meier and Cox-regression analyses. Results: Compared to the NPC group, the non-NPC group had a higher frequency of significant CAS (12.7% vs. 2.0%) and were more commonly associated with significant CAS after adjusting the covariates (Adjusted hazard ratio: 0.17, 95% confident interval: 0.05−0.57) during the follow-up period. All the non-NPC subtypes (oral cancer/oropharyngeal, hypopharyngeal, and laryngeal cancers) were associated with higher risks of significant CAS than the NPC group (p < 0.001 respectively). Conclusion: Significant CAS was more frequently noted within 5 years of RT among the patients with non-NPC HNC than among the patients with NPC. Scheduled carotid artery surveillance and vascular risk monitoring should be commenced earlier for patients with non-NPC HNC. By contrast, vascular surveillance could be deferred to 5 years after RT completion in NPC patients.
研究放射治疗(RT)后不久颈颅血管并发症的发生率,并确定不同类型头颈癌(HNC)患者之间的差异。方法:我们纳入了496例在我院接受最终放疗剂量的HNC患者。这些患者接受了颈动脉双功超声(CDU)检查以监测严重颈动脉狭窄(CAS)。回顾脑部影像学检查以检测放疗前的椎动脉、颅内动脉狭窄或已存在的CAS。主要结局是放疗后5年内颈内动脉或颈总动脉出现严重CAS。我们将患者分为鼻咽癌(NPC)组和非NPC组,并使用Kaplan-Meier和Cox回归分析比较两组之间严重CAS的累积发生率。结果:与NPC组相比,非NPC组严重CAS的发生率更高(12.7%对2.0%),并且在随访期间调整协变量后更常出现严重CAS(调整后的风险比:0.17,95%置信区间:0.05-0.57)。所有非NPC亚型(口腔癌/口咽癌、下咽癌和喉癌)与严重CAS的风险均高于NPC组(p分别<0.001)。结论:非NPC型HNC患者在放疗后5年内出现严重CAS的情况比NPC患者更常见。对于非NPC型HNC患者,应更早开始定期颈动脉监测和血管风险监测。相比之下,NPC患者的血管监测可推迟至放疗完成后5年。